💊Pharmacology for Nurses Unit 27 – Thyroid & Parathyroid Medication

Thyroid and parathyroid glands play crucial roles in regulating metabolism and calcium levels. Disorders of these glands can lead to significant health issues, affecting various body systems. Understanding the function and treatment of these glands is essential for nurses. Medications for thyroid and parathyroid disorders aim to restore hormonal balance and manage symptoms. From levothyroxine for hypothyroidism to calcium supplements for hypoparathyroidism, nurses must be familiar with these treatments to provide effective care and patient education.

Key Concepts

  • Thyroid gland secretes hormones that regulate metabolism, growth, and development
  • Parathyroid glands secrete parathyroid hormone (PTH) which regulates calcium levels in the body
  • Hypothyroidism occurs when the thyroid gland produces insufficient thyroid hormones
  • Hyperthyroidism results from excessive production of thyroid hormones
  • Medications used to treat thyroid disorders include levothyroxine, methimazole, and propylthiouracil
  • Hyperparathyroidism is characterized by elevated levels of PTH and hypercalcemia
  • Hypoparathyroidism is a condition of decreased PTH secretion and hypocalcemia
  • Nurses play a crucial role in monitoring patients' response to thyroid and parathyroid medications

Anatomy and Physiology Review

  • Thyroid gland is a butterfly-shaped endocrine gland located in the neck
    • Consists of two lobes connected by an isthmus
  • Thyroid follicular cells produce and secrete thyroid hormones (T3 and T4)
    • Synthesis of thyroid hormones requires iodine
  • Thyroid hormones regulate basal metabolic rate, growth, and development
  • Parathyroid glands are four small glands embedded in the posterior surface of the thyroid gland
  • Parathyroid glands secrete PTH in response to low serum calcium levels
  • PTH increases serum calcium levels by promoting bone resorption, renal calcium reabsorption, and intestinal calcium absorption
  • Negative feedback mechanisms regulate the secretion of thyroid hormones and PTH

Types of Thyroid Disorders

  • Hypothyroidism is a condition of insufficient thyroid hormone production
    • Causes include autoimmune disorders (Hashimoto's thyroiditis), iodine deficiency, and surgical removal of the thyroid gland
    • Symptoms include fatigue, weight gain, cold intolerance, and dry skin
  • Hyperthyroidism is characterized by excessive thyroid hormone production
    • Causes include Graves' disease, toxic multinodular goiter, and thyroiditis
    • Symptoms include weight loss, heat intolerance, palpitations, and anxiety
  • Goiter refers to an enlarged thyroid gland, which can be associated with both hypothyroidism and hyperthyroidism
  • Thyroid nodules are solid or fluid-filled lumps within the thyroid gland
    • Most thyroid nodules are benign, but some may be malignant (thyroid cancer)
  • Thyroiditis is inflammation of the thyroid gland, which can cause transient hyperthyroidism followed by hypothyroidism

Thyroid Medications

  • Levothyroxine is a synthetic form of T4 used to treat hypothyroidism
    • Administered orally, typically once daily on an empty stomach
    • Dosage is adjusted based on thyroid function tests (TSH, free T4)
  • Methimazole and propylthiouracil (PTU) are antithyroid medications used to treat hyperthyroidism
    • Inhibit the synthesis of thyroid hormones by blocking the enzyme thyroid peroxidase
    • Methimazole is preferred due to a lower risk of hepatotoxicity compared to PTU
  • Radioactive iodine (I-131) is used to treat hyperthyroidism and thyroid cancer
    • Concentrated in thyroid cells, causing localized destruction of the gland
  • Beta-blockers (propranolol) are used to manage symptomatic hyperthyroidism
    • Alleviate symptoms such as palpitations, tremors, and anxiety

Parathyroid Disorders

  • Hyperparathyroidism is a condition of excessive PTH secretion
    • Primary hyperparathyroidism is caused by parathyroid adenomas or hyperplasia
    • Secondary hyperparathyroidism occurs in response to chronic hypocalcemia (renal failure, vitamin D deficiency)
    • Symptoms include bone pain, kidney stones, abdominal pain, and fatigue
  • Hypoparathyroidism is characterized by insufficient PTH secretion
    • Causes include surgical removal of parathyroid glands, autoimmune disorders, and genetic mutations
    • Symptoms include muscle cramps, tingling sensations, and seizures due to hypocalcemia
  • Pseudohypoparathyroidism is a rare genetic disorder characterized by resistance to PTH
    • Results in hypocalcemia and hyperphosphatemia despite normal or elevated PTH levels

Parathyroid Medications

  • Calcium supplements are used to treat hypocalcemia in hypoparathyroidism
    • Administered orally in divided doses to maintain serum calcium levels within the normal range
  • Vitamin D analogs (calcitriol) are used in conjunction with calcium supplements to enhance intestinal calcium absorption
    • Calcitriol is the active form of vitamin D and directly stimulates calcium absorption
  • Cinacalcet is a calcimimetic medication used to treat secondary hyperparathyroidism in patients with chronic kidney disease
    • Activates calcium-sensing receptors on parathyroid cells, suppressing PTH secretion
  • Bisphosphonates (alendronate) may be used to treat bone loss associated with hyperparathyroidism
    • Inhibit bone resorption and increase bone mineral density

Nursing Considerations

  • Monitor thyroid function tests (TSH, free T4) regularly in patients taking thyroid medications
    • Assess for signs and symptoms of hypothyroidism or hyperthyroidism
  • Educate patients on the importance of taking thyroid medications consistently and at the prescribed times
  • Monitor serum calcium and phosphate levels in patients with parathyroid disorders
    • Assess for signs and symptoms of hypocalcemia or hypercalcemia
  • Encourage patients with hypoparathyroidism to maintain an adequate intake of calcium and vitamin D through diet and supplements
  • Assess patients taking cinacalcet for signs of hypocalcemia (muscle cramps, tingling sensations)
  • Collaborate with healthcare providers to adjust medication dosages based on laboratory results and clinical response

Patient Education and Monitoring

  • Teach patients about the signs and symptoms of thyroid and parathyroid disorders
    • Emphasize the importance of reporting any new or worsening symptoms to their healthcare provider
  • Instruct patients on the proper administration of thyroid and parathyroid medications
    • Levothyroxine should be taken on an empty stomach, at least 30 minutes before breakfast
    • Calcium supplements should be taken in divided doses throughout the day
  • Encourage patients to maintain a balanced diet rich in calcium and vitamin D
    • Recommend dietary sources of calcium (dairy products, leafy greens) and vitamin D (fatty fish, fortified foods)
  • Advise patients to inform their healthcare provider about any new medications or supplements they are taking
    • Some medications (calcium carbonate, iron supplements) can interfere with the absorption of thyroid hormones
  • Emphasize the importance of regular follow-up visits to monitor thyroid and parathyroid function
    • Laboratory tests and clinical assessments help ensure optimal management of thyroid and parathyroid disorders


© 2024 Fiveable Inc. All rights reserved.
AP® and SAT® are trademarks registered by the College Board, which is not affiliated with, and does not endorse this website.

© 2024 Fiveable Inc. All rights reserved.
AP® and SAT® are trademarks registered by the College Board, which is not affiliated with, and does not endorse this website.